About CDYMAX
CDYMAX is a company. The company has 493 employees as of April 09, 2024. CDYMAX offers products and services including Oncology APIs and General APIs.
- Employees 493 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Cdymax (India) Pharma Private Limited
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$29.19 M (USD)2.28as on Mar 31, 2023
-
Net Profit
-$5.59 M (USD)-102.95as on Mar 31, 2023
-
EBITDA
-$3.2 M (USD)-838.58as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
493
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CDYMAX
CDYMAX offers a comprehensive portfolio of products and services, including Oncology APIs and General APIs.
Oncology Active Pharmaceutical Ingredients are produced with dedicated utilities and warehouses
General Active Pharmaceutical Ingredients are manufactured with separate lines and quality units
Funding Insights of CDYMAX
Detailed funding history for CDYMAX
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CDYMAX
Investment portfolio details for CDYMAX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CDYMAX
Detailed financials for CDYMAX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cdymax Comparisons
Peer comparison for CDYMAX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CDYMAX
Detailed competitors of CDYMAX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cdymax
Complete news archive for CDYMAX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CDYMAX
As of Apr 09, 2024, the latest employee count at CDYMAX is 493.
Annual revenue of CDYMAX is $29.19M as on Mar 31, 2023.
CDYMAX is identified as a manufacturer of Active Pharmaceutical Ingredients, including Oncology and General APIs, with facilities that support specific annual capacities and maintain dedicated utilities. Adherence to Health, Safety, and Environment practices is ensured, alongside various CSR initiatives such as policy implementation and annual returns for multiple years. Operations are based in Bangalore, India, with a focus on quality and compliance, as reflected in the companys structure and projects from 2020 to 2024.
CDYMAX offers Oncology APIs and General APIs.